Braun Bostich & Associates Inc. Bristol Myers Squibb CO Transaction History

Braun Bostich & Associates Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$63.71 - $70.74 $25,420 - $28,225	399 Added 11.34%	3,917 $250,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $231,167 - $262,196	3,518 New	3,518 $243,000
Q3 2020 Oct 09, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $4,921 - $6,419	100 New	100 $6,000
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $4,277 - $5,071	-100 Closed	0 $0
Q4 2017 May 21, 2018	BUY	$59.94 - $65.35 $5,994 - $6,534	100	100 $6,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

Stay updated on Braun Bostich & Associates Inc. with notifications on news.